碳离子放疗诱导局部晚期非小细胞肺癌症状性食管与气管支气管损伤的NTCP建模与预测
该回顾性研究基于184例接受局部效应模型I碳离子放疗的局部晚期非小细胞肺癌患者,建立食管和近端支气管树症状性损伤的Lyman-Kutcher-Burman正常组织并发症概率模型,并推导剂量约束。研究提出食管Dmax 78 Gy(RBE)、近端支气管树Dmax 80 Gy(RBE)的阈值,预期将毒性风险控制在5%以下,多变量列线图AUC-ROC为0.823-0.884。
要点
- 研究建立碳离子放疗下食管和近端支气管树症状性损伤的NTCP模型。
- 提出食管Dmax 78 Gy(RBE)、近端支气管树Dmax 80 Gy(RBE)剂量约束。
- 多变量列线图预测性能AUC-ROC达0.823-0.884。
核心结论
- 首次在局部晚期非小细胞肺癌碳离子放疗中建立食管和近端支气管树症状性毒性NTCP模型。
- ROC推导的最佳EUD阈值可区分低风险队列,各不良事件实际发生率≤1.9%。
- 提出的Dmax约束和多变量列线图有助于临床常规使用。
研究设计与样本
- 回顾性研究分析184例接受碳离子放疗的局部晚期非小细胞肺癌患者。
- 中位处方剂量77 Gy(RBE),分次剂量3.5 Gy(RBE)。
- 采用Lyman-Kutcher-Burman模型建立急性食管炎、晚期食管反应和晚期近端支气管树毒性NTCP模型。
主要发现
- 急性食管炎≥2级和晚期近端支气管树毒性≥2/≥3级的n值较低(分别为0.053±0.097、0.139±0.085、0.224±0.135),提示主要依赖高剂量区域。
- 晚期食管毒性≥2/≥3级的n值较高(0.381/0.362),建议采用Dmax和Dmean双重约束。
- ROC推导的最佳EUD阈值定义的低风险队列中各不良事件实际发生率≤1.9%。
- 多变量列线图整合高剂量指标和Dmean,AUC-ROC为0.823-0.884。
关键数值与推荐
- 食管Dmax阈值为78 Gy(RBE),近端支气管树Dmax阈值为80 Gy(RBE),预期将毒性风险限制在5%以下。
- 急性食管炎≥2级n值为0.053±0.097。
- 晚期近端支气管树毒性≥2级n值为0.139±0.085,≥3级n值为0.224±0.135。
- 晚期食管毒性≥2级n值为0.381,≥3级n值为0.362。
临床怎么用
- 碳离子放疗计划设计时可参考食管Dmax 78 Gy(RBE)和近端支气管树Dmax 80 Gy(RBE)约束。
- 对晚期食管毒性风险,应同时关注Dmax和Dmean双重约束。
- 可利用多变量列线图预测症状性食管和近端支气管树损伤风险。
局限性
- 回顾性研究设计。
- 样本量有限(184例)。
- 需要更大规模、更长随访的前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation-induced injuries (RIs) to the esophagus (ESO) and proximal bronchial tree (PBT) represent one of the most frequently observed symptomatic adverse events in locally advanced non-small cell lung cancer (LA-NSCLC). The establishment of validated normal tissue complication probability (NTCP) models and subsequent dose constraint recommendations are especially essential in carbon-ion radiotherapy (CIRT), owing to its unique physical and biological properties. PURPOSE: To establish NTCP models and derive corresponding dose constraints for symptomatic or severe RIs in ESO and PBT in LA-NSCLC treated with local effect model (LEM)-I-based CIRT. METHODS: This retrospective study analyzed 184 LA-NSCLC patients treated with CIRT at a median prescription dose of 77 Gy (RBE) in 3.5 Gy (RBE) per fraction. Lyman-Kutcher-Burman (LKB) NTCP models were developed for acute esophagitis (ARI-ESO), late ESO reaction (LRI-ESO), and late PBT toxicity (LRI-PBT). Predictive performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC) by comparing single dosimetric parameters versus multivariate nomograms. RESULTS: For grade ≥ 2 (symptomatic) ARI-ESO and grade ≥ 2/≥3 (severe) LRI-PBT, low n values (0.053±0.097, 0.139 ± 0.085, 0.224 ± 0.135, respectively) indicated predominant dependence on high-dose regions. In contrast, higher n values (0.381/0.362) observed for grade ≥ 2/≥3 late ESO toxicities suggested the use of dual constraints incorporating both maximum dose (Dmax) and mean dose (Dmean). The best equivalent uniform dose (EUD) thresholds (ROC‑derived) defined a low‑risk cohort with an actual incidence of ≤1.9% for each adverse event. The proposed Dmax thresholds of 78 Gy (RBE) for ESO and 80 Gy (RBE) for PBT are expected to limit toxicity risk below 5%. Multivariate nomograms integrating high-dose metrics and Dmean achieved AUC-ROC values of 0.823-0.884. CONCLUSIONS: The first NTCP models for symptomatic toxicities of ESO and PBT were established in LA-NSCLC patients receiving LEM-I-based CIRT at ~3.5 Gy (RBE) per fraction with sequential systemic therapy. The ROC‑derived optimal EUD thresholds for discriminating NTCP risk were obtained with substantial AUC-ROC values. We also proposed NTCP-derived Dmax constraints and developed multivariate nomograms to facilitate routine clinical use. Further prospective studies in larger cohorts with extended follow-up were warranted.
引用
- Ming X, Ma N, Sheng Y, et al. Normal tissue complication probability modelling and predicting for carbon-ion radiotherapy-induced symptomatic esophageal and tracheobronchial injuries in locally advanced non-small cell lung cancer. Radiat Oncol. 2026. PMID: 42316224. doi:10.1186/s13014-026-02877-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。